A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report

Eitemau Tebyg

• Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma
  gan: Yasushi Rino M.D., et al.
  Cyhoeddwyd: (2008-01-01)
• Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma
  gan: Rino, Yasushi, et al.
  Cyhoeddwyd: (2008)
• Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
  gan: RINO, YASUSHI, et al.
  Cyhoeddwyd: (2013)
• Primary placement technique of jejunostomy using the entristar™ skin-level gastrostomy tube in patients with esophageal cancer
  gan: Wada Nobuyuki, et al.
  Cyhoeddwyd: (2011-01-01)
• Primary placement technique of jejunostomy using the entristar™ skin-level gastrostomy tube in patients with esophageal cancer
  gan: Rino, Yasushi, et al.
  Cyhoeddwyd: (2011)